全球膀胱鏡市場 - 市場規模（依細分市場）、佔有率、監管、償付、手術、運行設備數量、預測（~2033年）

老年患者數量的增加是膀胱鏡市場的成長因素之一。隨著老年族群中泌尿道感染的流行和腎癌發生率的增加，用於尿道診斷的膀胱鏡檢查越來越多。

本報告研究和分析了全球膀胱鏡市場，提供了有關主要參與者、市場佔有率、主要趨勢、創新產品和技術以及競爭格局的資訊。

市場模型的主要內容如下。

市面上已有的膀胱鏡以及不斷變化的競爭格局

• 對主要產業趨勢的考察
• 依細分市場劃分的膀胱鏡檢查市場年收入和市場前景（2015-2033年）
• 依細分市場劃分的總營業量、單位數量、平均售價和市場價值的詳細資料

全球、區域和國家層面的特定市場考察

• 依地區細分全球趨勢的特定市場定性資訊和國家考察
• 膀胱鏡市場SWOT分析
• 膀胱鏡市場競爭動態的考察與趨勢

掌握包括醫療保健系統概述真實情況，促進市場了解。市場進入部分還提供有關償付政策和監管環境的訊息，能夠更深入地研究市場動態。

• 各國醫療保健系統概覽
• 依國家/地區劃分的償付政策
• 各國醫療科技監理狀況

目標公司

• Olympus Corp
• KARL STORZ SE & Co KG
• PENTAX Medical Co
• Stryker Corp
• Richard Wolf GmbH
• Laborie Medical Technologies Inc
• Ambu A/S
• NeoScope Inc
• Coloplast A/S
• 其他

Cystoscopes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Endoscopy Devices therapeutic area.

Cystoscope is a device used for examining and treating lesions of the urethra or bladder. A Cystoscope is recommended for the conditions such as urinary tract infections, blood in the urine, loss of bladder control, unusual cells found in urine sample, painful urination, interstitial cystitis, urinary blockage from prostate enlargement, narrowing and presence of stone in the urinary tract, unusual growth, polyp, and cancer.

Cystoscopes are used for examining and treating lesions of the urethra or bladder.

The increasing population of elderly patients is one of the factors contributing to the growing cystoscopy market. With the rising prevalence of urinary tract infections in the aging population and increasing rates of renal cancer, cystoscopy for urethra based diagnosis is on the rise.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes and installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Cystoscopes and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Cystoscopes market revenue by segment and market outlooks from 2015-2033.
• Granular data on total installed base, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Cystoscopes market.
• Competitive dynamics insights and trends provided for Cystoscopes market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Olympus Corp, KARL STORZ SE & Co KG, PENTAX Medical Co, Stryker Corp, Richard Wolf GmbH, Laborie Medical Technologies Inc, Ambu A/S, NeoScope Inc, Coloplast A/S, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Cystoscopes marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Cystoscopes market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Cystoscopes market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Cystoscopes market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.